March 31, 2025
TOPLINE: Inotuzumab ozogamicin (IO), an anti‐CD22 antibody conjugated with calicheamicin, was well tolerated and demonstrated an overall response rate of 74% in adult patients with relapsed/refractory […]
March 31, 2025
TOPLINE: Human leukocyte antigen B27 (HLA-B27) positivity was associated with higher odds of non-remission in patients with juvenile idiopathic arthritis (JIA) at 18 years after disease […]
March 31, 2025
TOPLINE: The prevalence of cerebral small vessel disease (CSVD) nearly doubled over 7.5 years in neurologically asymptomatic patients with type 1 diabetes (T1D). The progression of […]
March 31, 2025
TOPLINE: In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age […]
March 31, 2025
TOPLINE: Echocardiography was associated with survival time and readmission in patients with type 2 diabetes (T2D). Moreover, it was positively correlated with survival time in patients […]
March 31, 2025
TOPLINE: Daily use of electronic screens shortly before bed was associated with a 33% higher rate of poor sleep and approximately 50 minutes less sleep weekly. […]
March 31, 2025
TOPLINE: Compared with no treatment, aspirin use was associated with an increased risk for acute kidney injury (AKI) in critical patients with chest trauma, a new […]
March 28, 2025
TOPLINE: Neoadjuvant chemotherapy (NACT) use in triple-negative breast cancer (TNBC) increased from 19.1% to 56.4% between 2010 and 2021, with pathologic complete response (pCR) rates rising […]
March 28, 2025
TOPLINE: High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a new trial showed. […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186
Next page